Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: * 30-80 years of age * Individuals with chronic impaired immune status * History of high-grade lower genital tract neoplasia (LGTN), Zubrod Performance Status of 0-2; Exclusion Criteria: * Patients treated for aHSIL less than 6 months before screening, * History of anal cancer and pregnant women.
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.